Study S000671

The Desire PLUS Study - Effects of Glucagon-like-Peptide-1 Analogues on Sexuality: a Prospective Open-label Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05598008
Acronym: Desire PLUS
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 85
Start: 2022-11-25
Primary completion: 2025-10-24
Lead sponsor: University Hospital, Basel, Switzerland
Conditions: Sexual Desire
Results posted: FALSE

Registered primary outcomes

Change in the German short version of the Sexual Desire Inventory (SDI-2) total score to assess sexual functioning [At baseline (before start of treatment, at V1) and after 4-6 months of treatment (V2)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.